Clinical Activity of Icotinib in Patients With Advanced Non-small-cell Lung Cancer Harbouring Uncommon EGFR Mutations: a Single-arm, Prospective, Phase 2 Study
Latest Information Update: 27 Sep 2023
At a glance
- Drugs Icotinib (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 14 Nov 2016 New trial record
- 10 Nov 2016 Status changed from not yet recruiting to recruiting.